MedPath

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo)

Not Applicable
Completed
Conditions
Pharynx; Anomaly
Apnea, Postanesthetic
Desaturation of Blood
Larynx Disease
Anesthesia
Apnea
Interventions
Device: optiflow
Registration Number
NCT03843580
Lead Sponsor
University Hospital, Caen
Brief Summary

Suspension laryngoscopy is realised during apnea. In effect, surgeons are in the mouth of the patient and we can't have access at the aiways.

So investigators like to use a Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) to increase time of apnea and decrease the impact of oxygen desaturation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • suspension laryngoscopy
Exclusion Criteria
  • THRIVE contraindication:
  • epistaxis
  • undrained pneumothorax
  • Recent gastroesophageal surgery (1months)
  • Skull Fractures

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
oxygenation optiflowoptiflowoptiflow oxygenation during apnea
Primary Outcome Measures
NameTimeMethod
desaturation defined as the number of patient who presented at least one desaturation during suspension laryngoscopyTwo hours

the number of patient who presented at least one desaturation during suspension laryngoscopy. An oxygen desaturation define like SpO2\<96%

Secondary Outcome Measures
NameTimeMethod
hypoxemia (decrease the number of Hypoxemia event define like SpO2<90%)2 hours

Decrease the number of Hypoxemia event define like SpO2\<90%

side effect2 hours

decrease the number of side effects

Trial Locations

Locations (2)

Centre François Baclesse

🇫🇷

Caen, France

CaenUH

🇫🇷

Caen, Normandie, France

© Copyright 2025. All Rights Reserved by MedPath